Mauch, L., Lun, A., O'Gorman, M. R. G., Harris, J. S., Schulze, I., Zychlinsky, A., Fuchs, T., Oelschlägel, U., Brenner, S., Kutter, D., Rösen-Wolff, A., & Roesler, J. (2007). Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clinical Chemistry, 53(5), 890-896. doi:10.1373/clinchem.2006.083444.
